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Abstract Human beings have been recently reviewed
as ‘metaorganisms’ as a result of a close symbiotic
relationship with the intestinal microbiota. This
assumption imposes a more holistic view of the
ageing process where dynamics of the interaction
between environment, intestinal microbiota and host
must be taken into consideration. Age-related physi-
ological changes in the gastrointestinal tract, as well
as modification in lifestyle, nutritional behaviour, and
functionality of the host immune system, inevitably
affect the gut microbial ecosystem. Here we review
the current knowledge of the changes occurring in the
gut microbiota of old people, especially in the light of
the most recent applications of the modern molecular
characterisation techniques. The hypothetical involve-
ment of the age-related gut microbiota unbalances in
the inflamm-aging, and immunosenescence processes
will also be discussed. Increasing evidence of the
importance of the gut microbiota homeostasis for the
host health has led to the consideration of medical/
nutritional applications of this knowledge through the
development of probiotic and prebiotic preparations
specific for the aged population. The results of the
few intervention trials reporting the use of pro/
prebiotics in clinical conditions typical of the elderly
will be critically reviewed.
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Introduction
The microbial community which inhabits the human
gastrointestinal (GI) tract is widely recognized as a
key component of GI homeostasis, playing an
essential role in maintaining human health. The
perceived importance of the intestinal microbiota in
human physiology culminated in the review of human
beings as ‘metaorganisms’ derived from millennia of
co-evolution with their own indigenous intestinal
microbiota (Turnbaugh et al. 2007). In the light of
the metaorganism hypothesis, a more holistic view of
the process of human ageing has been suggested
where the ageing of the microbial counterpart is
regarded as an important actor. The balance of the
intestinal microbiota is inevitably affected by the
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ageing process itself, as well as other age-related
events, i.e. modification in diet and lifestyle, and
reduction of functionality of the immune system (IS).
Therefore, changes in the composition and structure
of the intestinal microbiota could be related to
distinctive conditions of the elderly, such as frailty,
immunosenescence, metabolic syndrome, diabetes
and sarcopenia.
Although this is a field of growing interest because
of the increasing proportion of aged individuals in the
Western countries (Cohen 2003; Christensen et al.
2009), studies focused on the changes which occur in
the intestinal microbiota during the ageing process
and their possible consequences on the health status
of the elderly are still limited. The purpose of this
review is to discuss the current knowledge of the
microbial diversity in the gut of elderly people. The
possibility of preventing or modulating the age-
associated modifications in gut microbiota through
dietary supplementation (pro/prebiotics) or other
approaches, aimed at obtaining beneficial effects on
the host’s health, will also be reviewed.
Physiology, nutrition and lifestyle of the elderly
Physiological changes and effects of diet
In old age, there is an increased threshold for taste and
smell (Weiffenbach and Bartoshuk 1992; Doty et al.
1984), and there may be subtle changes in gastroin-
testinal motility (Orr and Chen 2002). Masticatory
dysfunction caused by loss of teeth and muscle bulk
(Newton et al. 1993) can lead to the consumption of a
restricted, nutritionally imbalanced diet. Edentulous
persons and those who rate their health as fair or poor
generally consume fewer servings of fruits and
vegetables, eat a less varied diet and have a poorer
quality diet than people with teeth (Ervin 2008).
Physiological functions naturally decline with age
and may influence the absorption and/or metabolism
of nutrients. Gastric atrophy in the elderly has been
reported to be responsible for reduced absorption of
calcium, iron and vitamin B12 (Russell 1992) and
results in an inability to release cobalamin from food
or its binding proteins (Dali-Youcef and Andrès
2009), causing vitamin B12 deficiency. Helicobacter
pylori infection is also associated with vitamin B12
deficiency (Allen 2008), and epidemiological studies
have demonstrated that both gastric atrophy and H.
pylori infection increase with ageing (Pilotto et al.
1999; Fernández-Bañares et al. 2009). In people over
75 years, the combination of gastric atrophy and H.
pylori has also been associated with lower expression
of gut appetite proteins, leptin and ghrelin, which
raises the possibility that H. pylori may be contribut-
ing towards undernutrition in the elderly (Salles et al.
2006).
There is higher incidence of diverticular disease in
old age (Raskin 2008), currently believed to be
associated with localised inflammation, and this is
exacerbated by a low fibre diet (Comparato et al.
2007). Insoluble fibre from fruits and vegetables are
reported to be more beneficial than cereal fibre both
for the prevention and treatment of diverticular
disease (Aldoori et al. 1998). Intakes of dietary fibre
display differences between countries, with Sweden
having the lowest intake (17.0 g/day in men aged 65–
74 years) and Murcia, Spain the highest (29.4 g/day).
Interestingly, UK women aged 65–74 years who are
described as ‘health conscious’ have a much higher
fibre intake, 24.5 g/day compared with 15.8 g/day in
the general female population of this age (Cust et al.
2009). The UK National Diet and Nutrition Survey
(NDNS) of the Elderly (Finch et al. 1998) report a
significant fall in non-starch polysaccharides with
increasing age, with intakes of 13.5 and 11.0 g/day for
free-living and institutionalised men, respectively, and
11.0 and 9.5 g/day for women with cereals and cereal
products providing about half the total fibre intake.
There was a positive association between the number
of bowel movements and average daily non-starch
polysaccharide intake.
Constipation is more common with increasing age
and is caused by inactivity, inappropriate diet,
depression and confusion, certain medications and
neuromuscular disorders (Wald 1993). Commonly
this is treated with laxatives but ideally the consump-
tion of whole grains, legumes, fruits and vegetables
should be increased (Slavin 2008). Tailored products,
such as pea hull fibre added to usual foods (Dahl et al.
2003) and oat bran (Sturtzel et al. 2010), have been
shown to be helpful in improving constipation
management, and oat bran was also reported to
improve vitamin B12 bioavailability.
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Dietary patterns may undergo a series of changes in
older life, modulated by many age-related factors
such as changes in socioeconomic status, mobility,
dentition, taste, smell, digestion, appetite and con-
ditions such as depression and dementia (Koehler and
Leonhaeuser 2008). Dean et al. (2009) report that
appetite, food knowledge, perceived distance to the
shops, access to high-quality food products, kitchen
facilities and support from friends and neighbours all
contribute to the selection of a varied diet which
broadly determines its nutritional quality. Living
alone in old age is associated with a poor diet, even
when an allowance is made for age, sex, income and
educational attainment (Kharicha et al. 2007).
The quality of the diet in old age has a significant
impact on morbidity and mortality (de Groot et al.
2004), and there is a growing risk of malnutrition with
increasing age. For example, in a small study in the
UK, Harris et al. (2008) observed that 10% of people
(mean age 79 years) living in sheltered accommoda-
tion were malnourished according to the Malnutrition
Universal Screening Tool and Mini Nutritional As-
sessment. The UK NDNS of the Elderly (Finch et al.
1998) reported low riboflavin status in 40% of free-
living and institutionalised men and women aged
65 years and over, low plasmavitamin C concentrations
in 15% of free-living and 40% of institutionalised
people, low thiamine status in 10–15% of both groups,
lowredbloodcellfolatein8%offree-livingand19%of
institutionalised people and low serum vitamin B12 in
6% of free-living and 9% of institutionalised people.
There was wide inter-individual variability in all of the
status measurements, reflecting variation in quality of
the diet. Mean plasma 25-hydroxyvitamin D concen-
trations <25 nmol/L were present in 8% of free-living
and 37% of institutionalised people, with a clear
seasonal variation and a downward trend in free-
living individuals. However, this lower limit is based
on preventing rickets and osteomalacia and is
c u r r e n t l yc o n s i d e r e dt ob et o ol o wf o rt h eo t h e r
health-related functions of vitamin D (Vieth et al.
2007; Henry et al. 2010), suggesting that the
problem of inadequate vitamin D status is even more
widespread in old people living in Northern Europe,
particularly those who are confined indoors (Dixon
et al. 2006).
The UK NDNS of the Elderly (Finch et al. 1998)
reported inadequate intakes for a number of minerals,
including magnesium (21–39% had intakes below the
lower reference nutrient intake (LRNI), indicating a
97.5% probability of deficiency), potassium (17–42%
below the LRNI) and zinc (4–13% below the LRNI),
but the lack of biomarkers of status makes it
impossible to confirm the presence of deficiency and
the level of risk is dependent on the appropriateness
of the LRNI value. In contrast, reported inadequate
intakes of iron (1–6% below the LRNI) are accom-
panied by low haemoglobin concentrations (indicative
of anaemia) in 11% and 9% of free-living and 52%
and 39% of institutionalised men and women,
respectively, illustrating the problem of inadequate
iron supply in the diet of UK elderly, particularly
those living in residential homes. In the general
population across Europe, there is geographical
variability in mineral intakes (Welch et al. 2009). In
men aged 65–74 years, magnesium intakes ranged
from 352 mg/day in Malmö, Sweden to 475 mg/day
in Murcia, Spain, and in women, the lowest intake
was in Naples, Italy (252 mg/day) and highest in
northwest France (384 mg/day). Iron intakes also
vary, with higher intakes in Southern than in Northern
Europe. In men aged 65–74 years, the range was
between 12.1 mg/day (Malmö, Sweden) to 19.9 mg/
day (Greece); in women, the range was 8.8 mg/day
(Malmö, Sweden) to 14.2 (Greece).
Drugs
Elderly patients are the recipients of more than 30%
of all prescription drugs, often given as multiple
treatments, so are at higher risk of compromised
nutritional status because of drug–nutrient interac-
tions, for example, loss of body electrolytes (Genser
2008). Adverse drug reactions are at least twice as
common in the elderly compared to younger adults,
but the side effects are not well-documented in this
age group since most clinical trials exclude patients
>75–80 years. Malabsorption, diarrhoea and consti-
pation are common side effects of laxatives, anti-
biotics, anticholinergics and calcium channel blockers
(Triantafyllou et al. 2010). However, the purported
long-term adverse effects of proton pump inhibitors
on vitamin B12 status have recently been refuted (den
Elzen et al. 2008).
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25% of all cases of antibiotic-associated diarrhoea
(Poutanen and Simor 2004). C. difficile-associated
diarrhoea (CDAD) is a common problem in geriatric
care, especially in elderly hospitalised patients with
comorbid illnesses and ongoing exposure to antibiotics;
prolongedstaysinintensivecareunitsmayalsobearisk
factor for C. difficile infection (Monaghan et al. 2008;
Cober and Malani 2009;K e l l y2009). Usually it occurs
2 to 3 weeks after cessation of antibiotic treatments
(Barbut and Petit 2001), and although most patients are
responsive to metronidazole and vancomycin therapy,
20% to 35% of them present recurrent symptoms
which can end up in repeated episodes of diarrhoea
over months to years, resulting in an increased
morbidity and reduced quality of life (McFarland et
al. 2002;P o u t a n e na n dS i m o r2004).
Gut microbiota and human health
The GI tract harbours the largest and most complex
bacterial ecosystem in the human body (Hattori and
Taylor 2009; Neish 2009). An increasing gradient in
bacterial concentration characterises the human GI
tract, from stomach, to jejunum, ileum and colon,
where the concentration peaks to 10
11–10
12 bacterial
cells per gram of stool (Ley et al. 2006a; Leser and
Molbak 2009). The collective genome of the gut
microbial community (microbiome) contains more than
100 times the number of genes in the human genome
(Backhed et al. 2005), endowing human hosts with
physiological attributes they did not evolve on their
own. The gut microbiota enhances the host’sm e t a b o l i c
capabilities by hydrolysing complex plant polysacchar-
ides poorly digested by the human digestive system
and producing short chain fatty acids (SCFA). SCFAs
positively affect energy transduction in colonocytes,
growth and cellular differentiation and hepatic control
of the lipid and carbohydrate metabolism (Cummings
1995; Topping and Clifton 2001). Moreover, several
SCFAs have shown to exert anti-inflammatory and
immunomodulatory effects (Macfarlane et al. 2007).
Microbes in the human gut are also responsible for the
synthesis of certain essential vitamins and amino acids
(Hooper et al. 2002). Other benefits provided by the
gut microbiota are involved in the development and
maintenance of the IS homeostasis (Round and
Mazmanian 2009) and in the development and survival
of the gut epithelium (Neish 2009). Finally, the gut
microbiota exerts a right of ‘first occupancy’ preclud-
ing other microorganisms from invading the occupied
niches (Sansonetti and Medzhitov 2009).
The total diversity ofa healthyadult gut ecosystem is
generally reported to be around 1,000–1,200 species-
level phylogenetic types (phylotypes, defined as groups
of 16S ribosomal RNA (rRNA) gene sequences with
97–99% of similarity) of which 75–82% is estimated to
remain uncultured (Eckburg et al. 2005; Flint et al.
2007;R a j i l i c - S t o j a n o v i ce ta l .2007;X ue ta l .2007).
The vast majority of this diversity (90–99%) is
confined to the bacterial phyla Firmicutes and Bacter-
oidetes, with the dominant Firmicutes (50–80%)
primarily composed of bacteria belonging to the
Clostridium clusters XIVa and IV. Other phyla repre-
sented in the human gut are Actinobacteria (3–15%),
Proteobacteria (1–20%), Verrucomicrobia (0.1%),
Fusobacteria, Cyanobacteria, Spyrochaetes and Lenti-
sphaerae (Ley et al. 2006b; Turnbaugh et al. 2006;
Frank et al. 2007; Andersson et al. 2008;A r m o u g o m
and Raoult 2008; Dethlefsen et al. 2008; Tap et al.
2009). This adult-like structure of the gut microbiota is
established approximately after the first year of life, and
it is believed to remain relatively stable through healthy
adulthood (Vanhoutte et al. 2004). In spite of the
astonishing individual variability in terms of species
and strain composition showed by the gut microbiota
(Zoetendal et al. 1998, 2001; Eckburg et al. 2005;L a y
et al. 2005; Ley et al. 2006a), a high degree of
conservation in the expressed functions and metabo-
lites of the gut microbiota has been reported (‘func-
tional redundancy’;G i l le ta l .2006;M a h o w a l de ta l .
2009; Tschop et al. 2009; Turnbaugh et al. 2009). On
the contrary, major alterations in the gut microbiota
structure, such as modifications at the level of order/
phylum (dysbiosis), affect the microbiota functionality.
Even if it is still impossible to define a cause–effect
relation between dysbioses and the occurrence of a
pathological situation, the maintenance of a balanced
microbiota may represent a new frontier of biology and
medicine in which new strategies for preserving human
health may be identified (Hattori and Taylor 2009).
Age-related reshaping of the gut microbiota
The available literature concerning the composition of
gut microbiota in the elderly is sparse, and only
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(Fig. 1) have been applied to this particular field of
the gut microbial ecology. Results obtained by bacterial
isolation techniques (Hopkins and Macfarlane 2002;
Woodmansey et al. 2004)c a n n o tb ec o m p a r e dw i t h
data from more advanced techniques for the molecular
characterisation of the microbiota, now considered
essential to obtain a comprehensive view of the gut
ecosystem.
Moreover, the different studies are generally not
comparable since they often have different purposes,
such as the relationship between microbiota and frailty
(van Tongeren et al. 2005), the impact of antibiotic
treatments (Bartosch et al. 2004; Woodmansey et al.
2004) and the differences between the GI health status
of hospitalised and non-hospitalised patients (Bartosch
et al. 2004; Zwielehner et al. 2009). Even when only
healthy elderly are considered for the studies, there are
discrepancies in the definition of ‘elderly’:G r o u p so f
people with a wide range of age are often recruited, on
the basis of general ‘over 60’ (Mueller et al. 2006),
‘over 65’ (Woodmansey et al. 2004;C l a e s s o ne ta l .
2010)o r‘over 70’ (Mariat et al. 2009) criteria. This
makes it very difficult to define with accuracy any
‘threshold age’ at which time the gut environment
really begins to be affected by the ageing process.
Striking country-related differences in the effects of
age on the gut microbiota composition are also often
reported, suggesting that the different nutritional habits
and lifestyle of the elderly may play a role in
determining the age-related modifications.
In conclusion, the definition of the gut microbiota
of healthy elderly is still a challenging task. The
commonly reported age-related changes in the dom-
inant and subdominant microbiota are summarized in
the next sections, and the most recent studies in the
field are discussed.
Age-related modification in the dominant microbiota
Among the Firmicutes, Clostridium cluster XIVa (also
called Clostridium coccoides/Eubacterium rectale
group) was reported to decrease in Japanese healthy
elderly aged 74–94 years (Hayashi et al. 2003), Italian
over 60 years (Mueller et al. 2006) and Finnish over
70 years people (Mäkivuokko et al. 2010). Most
recently, Biagi et al. (2010) reported the same
modification in Italian centenarians. On the contrary,
German over 60 years elderly showed inverse trend
(Mueller et al. 2006). As for the Clostridium cluster IV,
a well-documented ageing effect is the decrease in the
Faecalibacterium prausnitzii group, a subset of this
cluster, reported in Italian over 60 years (Mueller et al.
2006) and Italian centenarians (Biagi et al. 2010). On
the contrary, the other European population con-
s i d e r e di nt h es t u d yo fM u e l l e re ta l .( F r a n c e ,
Germany and Sweden) showed an opposite trend,
as well as the Irish over 65 years elderly involved
in the study of Claesson et al. (2010). The decrease
of both Clostridium cluster XIVa and F. prausnitzii
group members was also correlated to frailty condition,
hospitalisation, antibiotic treatment and non-steroidal
anti-inflammatory therapy (Bartosch et al. 2004;v a n
Tongeren et al. 2005; Tiihonen et al. 2008;Z w i e l e h n e r
et al. 2009).
The effect of ageing on bacteria belonging to the
phylum Bacteroidetes is quite confusing. A decline in
the Bacteroidetes amount was showed by earlier
isolation studies (Hopkins and Macfarlane 2002;
Woodmansey et al. 2004) and confirmed by molecular
techniques for Italian healthy over 60 years people
(Mueller et al. 2006) and elderly subjects from
Northern Europe, aged 71 years in average (Rajilic-
Stojanovic et al. 2009). On the contrary, German
healthy elderly, Austrian hospitalised elderly patients
aged 78–94 years and Finnish over 70 years (Mueller
et al. 2006; Zwielehner et al. 2009; Mäkivuokko et al.
2010) showed an inverse trend. Thus, the behaviour
of the Bacteroidetes population during ageing seems
strongly country dependent, and according to studies
using 16S rRNA-based molecular techniques, a
decrease in Bacteroidetes seems to be more strictly
related to frailty condition, antibiotic treatment,
hospitalisation and CDAD, than to the ageing process
itself (Hopkins et al. 2001; Bartosch et al. 2004; van
Tongeren et al. 2005).
As Bacteroidetes and Firmicutes are the most
dominant phyla in the gut, the ratio between these
two groups of bacteria could be considered an
informative parameter of the overall status of the gut
microbiota. In this context, Mariat et al. (2009)
reported that the Firmicutes/Bacteroidetes ratio was
lower in elderly people (aged 70–90 years) than in
young adults, but the nationality of the enrolled
subjects was not stated in the paper. This was
confirmed by Claesson et al. (2010) in their recent
application of pyrosequencing performed on the
faecal microbiota of Irish young and elderly adults.
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significant differences among the Firmicutes/Bacter-
oidetes ratios of Italian centenarians, elderly and
young adults.
Age-related modifications in the subdominant
microbiota
The available studies are in general agreement reporting
an age-related increase in facultative anaerobes, includ-
ing streptococci, staphylococci, enterococci and enter-
obacteria (Gavini et al. 2001; Woodmansey et al. 2004;
Mueller et al. 2006; Mäkivuokko et al. 2010;M a r i a te t
al. 2009; Rajilic-Stojanovic et al. 2009). The enter-
obacteria group comprehends potentially pathogenic
species, recently redefined as ‘pathobionts’,i . e .b a c t e -
rial species present in small concentrations in a healthy
gut environment, which can overgrow in certain
situation, such as inflammation (Pédron and Sansonetti
2008), and be the cause of infections when the host
resistance mechanisms fail as a result of the ageing
process. Antibiotic treatment, hospitalisation and
CDAD are known to promote the increase of enter-
obacteria in the microbiota of elderly people (Hopkins
et al. 2001;B a r t o s c he ta l .2004; Woodmansey et al.
2004).
As for the health-promoting bacteria, the decrease
of bifidobacteria in the gut microbiota, both in terms
of abundance and species diversity, has been a
commonly accepted ageing effect in the past years
(Mitsuoka 1992; Gavini et al. 2001; Hopkins and
Macfarlane 2002; Woodmansey et al. 2004; Mueller
et al. 2006), magnified by antibiotic treatment,
hospitalisation and CDAD (Hopkins et al. 2001;
Bartosch et al. 2004;Z w i e l e h n e re ta l .2009).
However, several recent studies based on molecular
techniques do not seem to confirm this: Rajilic-
Stojanovic et al. (2009) did not find any difference
between the bifidobacteria abundance in healthy
elderly and young adults, nor did Biagi et al. (2010),
who reported a significant decrease in the bifidobac-
terial population only in extremely old people.
Lahtinen et al. (2009), in a study on elderly nursing
home residents, also pointed out that the average level
and species diversity of Bifidobacterium in elderly
was higher than expected. The discrepancies in the
Bifidobacterium behaviour with respect to the ageing
process may be explained, again, by country-related
differences, but also considering the remarkable
temporal instability of the Actinobacteria (the phylum
which includes the Bifidobacterium genus) population
in the faecal microbiota of the elderly, highlighted by
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Fig. 1 Molecular tools for the characterisation of the intestinal microbial community. For each tool, the principal advantages (black)a n d
disadvantages (white) are described
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Recent developing and open questions
A substantial improvement in understanding how the
ageing process affects the composition of the gut
microbiota has been recently provided by Biagi et al.
(2010) and Claesson et al. (2010), thanks to several
unique characteristics of their studies. The uniqueness
of the study of Biagi et al. resides in the recruitment
procedure: Three Italian populations—instead of two
—of Italian subjects, with very narrow ranges of age,
were enrolled: 21 centenarians (aged 99–104 years),
22 elderly (aged 63–76 years) and 20 young adults
(aged 25–40 years). The presence of the group of
exceptionally old individuals allowed the authors to
point out an unexpected similarity between the faecal
microbiota of young and elderly adults, whereas only
centenarians showed a markedly altered microbial
ecosystem. Briefly, the gut microbiota of centenar-
ians, analysed by using the human intestinal tract chip
(HITChip; Rajilic-Stojanovic et al. 2009), was found
to be enriched in facultative anaerobes, belonging to
the genera Bacillus, Streptococcus and several mem-
bers of the enterobacteria, whereas members of the
Clostridium cluster XIVa and the F. prausnitzii group
significantly decreased, approximately confirming
most of the results reported by Mueller et al. (2006)
for the Italian subsample, with the exception of the
decrease in the Bacteroidetes abundance. The lack of
significant differences between the gut ecosystems of
young adults and elderly in their seventies may be due
to the narrower range of age used by Biagi et al.
during the recruitment. The 39 Italian elderly
recruited by Mueller and coworkers were aged 61–
100 years, whereas in the study of Biagi et al., two
separate age groups were defined in the same interval,
allowing a better resolution. These observations lead
to the hypothesis that an average age of 70 years old
may not be ‘old enough’ to be considered ‘elderly’
when we are analysing the gut environment, at least
for the Italian population. A possible explanation may
reside in the fact that the gut microbiota is known to
be characterised by an astonishing resilience during
adult life: Drugs treatment, travelling, dietary changes
and so on are able to alter the balance of the gut
microbiota, but the lasting consequences of these
fluctuations are believed to be minimal. The ability of
the gut microbial ecosystem to maintain and/or
recover its balanced structure after an environmental
perturbation may be greater than expected. Conse-
quently, the age-related changes in physiology, life-
style and nutrition may need time to permanently
affect the gut microbiota. So, an interesting question
that still needs to be answered (Table 1) is how
changes in lifestyle can result in a permanently altered
gut microbiota? And assuming that the age-related
changes in the microbiota composition are progres-
sive, when do they become evident enough to be
sensed by the available characterisation techniques?
The results presented by Biagi et al. seem to highlight
that a healthy gut microbiota starts to be evidently
affected by the age-related physiological and behav-
ioural changes later than the age of 65, which is the
usual ‘threshold age’ to be defined as elderly.
However, these questions point out the lack of
longitudinal studies in this field: Monitoring the
changes in composition of the gut microbiota of the
same subject over several, crucial years of his life (e.g.
60–80 years) may be the only way to answer these
questions, thereby removing confounding effects of
inter-individual variability.
Furthermore,thedefinitionof‘elderly’itselfmayneed
to be revised, or better clarified, especially for what
concerns the progressive ageing of the human population
in Western countries. An increasing share of the elderly
population is composed of ‘very old’ people, aged
>85 years, i.e. ‘the oldest old group’ by Christensen et
al. (2009). Moreover, the number of ‘extremely old’
people, i.e. centenarians, in industrialized countries has
augmented about 20 times in the last 50 years (Roush
1996;T r o e n2003). Centenarians, who represents the
extreme limit of the human lifespan, are known to have
unusual features for which most of the current concepts
in biology and genetics are inadequate (De Benedictis
and Franceschi 2006) and, as such, cannot be consid-
ered simply ‘elderly’ a n dg r o u p e dt o g e t h e rw i t h
‘younger elderly’ (65–70 years old people) when we
are analysing age-related phenomena.
Lastly, it should not be surprising that the differences
found by Biagi et al. between the gut microbiota of
centenarians and younger people approximately
reflect those reported between elderly with high
and low frailty score (van Tongeren et al. 2005),
since the centenarians are obviously very frail. This
highlights the importance of carefully characterising
several health parameters, such as the frailty score, of
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the ageing process.
Immediately after the study of Biagi et al., another
remarkable paper was published on the topic by
Claesson et al. (2010). This study involved a very
large number (161) of Irish elderly subjects, aged 65–
96 years. Their faecal microbiota was characterised by
using the state-of-art of the molecular techniques, the
pyrosequencing, and compared to that of nine
younger adults (aged 28–46 years). Therefore, it
represents the largest and most intense analysis of
the elderly gut microbiota available to date. Unex-
pectedly, Bacteroidetes seemed to dominate the gut
microbiota of the elderly, instead of the Firmicutes.
Such strong modification in the asset of the gut
microbiota structure was never reported before for
elderly enrolled in other countries.
With the two most recent studies published in this
field (Biagi et al. 2010;C l a e s s o ne ta l .2010), the
country specificity pointed out by Mueller et al. (2006)
several years ago has emerged as even more striking.
For instance, the gut microbiota of the Irish population
seems to be characterised by a higher proportion of
Bacteroidetes than that of Italian people. In the case of
Irish people, this proportion increases with the ageing
process (from 41% to 57%, in average), whereas in
Italian elderly and centenarians, the proportion of
Bacteroidetes remains approximately constant (Biagi
et al. 2010) or even decreases (Mueller et al. 2006). It
is worth pointing out that the differences between the
results reported in these studies cannot be attributed to
the different molecular approaches, since HITChip and
pyrosequencing profiles have been already shown to
be comparable (Claesson et al. 2009). In addition, both
HITChip and pyrosequencing studies were in agree-
ment, reporting a higher inter-individual variability in
the microbiota profiles of older people.
The country specificity of age-related changes in
the gut microbiota composition and the country-
related differences in the gut microbiota itself are
interesting findings, likely to be explored further in
the next few years. With the aid of the newest
molecular techniques, studies in gut ecology will
probably determine how and to what extent lifestyle,
nutrition, climatic differences, environmental expo-
sure and so on can impact on the structure of the gut
microbiota and its response to physiological and
behavioural changes such as those which accompany
the ageing process.
Gut microbiota, immunosenescence
and inflamm-aging
The gut microbiota lives in close proximity to the gut
mucosal surface. This high microbial load on the
single cell epithelial layer undoubtedly represents a
persistent threat of microbial invasion. In order to
cope with this risk, humans evolved a specific
gastrointestinal IS engineered to limit tissue invasion
by intestinal microorganisms and to preserve the
symbiotic nature of this interaction (Hooper and
Macpherson 2010). The human gut-associated lym-
phoid tissue maintains the intestinal microbiota under
control by a ‘constitutive low-grade physiological
inflammation’ which is based on a web of positive
and negative biological feedback processes. The
peculiar biological architecture of the gastrointestinal
mucosal IS permits the distinction between harmful
pathogens and symbiotic microorganisms, generating
a strong effector response towards the former and
remaining tolerant to the latter. However, non-
infectious human diseases characterised by an aber-
rant intestinal inflammation, such as allergies, inflam-
matory bowel diseases, metabolic syndrome, as well
as genetic defect in enterocytes pattern recognition
receptors system, can cause a breakdown in the
homeostatic equilibrium between the intestinal micro-
Table 1 Interesting questions and hot topics
How do nationality-related features, such as diet, environment and life style, impact the ageing of the intestinal microbial community?
How does the individual physiological health status determine the threshold of ageing of the intestinal microbiota?
Can we find specific microbial metabolites biomarkers of the ageing process?
How is possible to modulate the ageing process of the intestinal microbiota?
Which is the right intervention time for the modulation of the ageing process of the human intestinal microbiota?
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between protective symbionts and opportunistic
pathogens (pathobionts) in favour of the latter
(Sansonetti 2011).
In old people, the IS functionality declines as a result
ofaprocessknownas‘immunosenescence’(Ostanetal.
2008; Shanley et al. 2009), and a chronic, low-grade
inflammatory status, called ‘inflamm-aging’,c h a r a c t e r -
ises the whole ageing organism (Franceschi 2007;
Franceschi et al. 2007; Larbi et al. 2008). Since the
inflamm-aging also ends up in a localised, persistent
inflammation at the level of the intestinal mucosa
which can contribute to the systemic inflammation, it
is important to understand how this process affects and/
or is affected by the gut bacterial inhabitants. In fact, it
has beenpostulatedthatthe inflammatoryprocess could
be caused and/or nurtured by an abnormally activated
immune response to the components of the gut micro-
biota, which may be due either to a diminished mucosal
tolerance, or to the age-related changes in the gut
microbiota composition, or both (Guigoz et al. 2008).
Nutritional deficiency and age-associated tissue weak-
ness and injuries may also contribute to trigger a
pathogenic inflammatory response in the presence of
normally harmless symbiotic bacteria (Schiffrin et al.
2009a). Moreover, pathobionts may take advantage of
the decline in IS reactivity and inflammatory status to
overgrow and nurture the inflammation process in a
sort of self-sustained loop. It is also possible that the
reduced bacterial excretion, due to the slower intestinal
transit, faecal impaction and constipation, may result in
an excessive ‘bacterial load challenge’, which is
known to be a critical determinant for the production
of several interleukins during inflammatory response
(Maloy 2008).
It may be hypothesised that the maintenance of a
‘healthy’ gut microbiota structure during ageing could
help in delaying or preventing the inflamm-aging
process. In fact, several gut bacterial species (belonging
to the genera Faecalibacterium, Bifidobacterium, Lacto-
bacillus) are known to be able to downregulate the pro-
inflammatory response at the level of the gut epithelium
(Tien et al. 2006; Sokol et al. 2008;H e u v e l i ne ta l .
2009; Van Baarlen et al. 2009), or, as in the case of
Bacteroides thetaiotaomicron, to indirectly prevent the
transcription of pro-inflammatory genes (Kelly et al.
2004). Ouwehand et al. (2008) demonstrated that the
amount of several autochthonous Bifidobacterium spe-
cies in the gut microbiota of elderly subjects is
negatively correlated with serum levels of the pro-
inflammatory cytokine TNF-α and the regulatory
cytokine interleukin-10 (IL-10), indicating that modula-
tion of the faecal bifidobacterial population may
represent a mean for reducing the inflammatory
response.
Biagi et al. (2010) provided a deeper view of the
correlation between the gut microbiota composition
and the levels of several serum inflammatory markers.
In their model of an extremely aged and consequently
compromised microbiota, a rearrangement was ob-
served in the population of butyrate producers and
other bacteria with anti-inflammatory properties, such
as F. prausnitzii. The resulting dysbiosis may be
among the causes—or the results—of the proliferation
of opportunistic enterobacteria, which seemed to be
positively correlated to an increase in some pro-
inflammatory signals (IL-6 and IL-8). The authors
hypothesised that the age-related proliferation of
pathobionts could either contribute to inflamm-aging
or be promoted by the systemic inflammatory status.
In spite of these recent findings, a direct involvement
of the autochthonous gut microbiota in the inflamm-
aging process has yet to be determined, since it is not
possible to understand if the observed differences
between the gut microbiota of older and younger adults
are either a consequence of the inflammatory status, or
among its causes. However, it has been recently
proposed that the age-associated increase in the intesti-
nal abundance of Enterobacteriaceae and other gram-
negative bacteria may result in an increased endotoxin
challenge for the weakened intestinal barrier, ending
up in an increased stimulation of the inflammatory
response (Schiffrin et al. 2009a).
From observation to action: probiotics
and prebiotics
The increased understanding of the impact of the gut
microbiota on human health has resulted in attempts to
manipulate its composition by the use of probiotics and
prebiotics, both in prophylactic and therapeutic per-
spectives. Probiotics are defined as living microorgan-
isms that provide a health benefit to the host when
ingested in adequate amounts (FAO/WHO 2001).
Effectiveness, safety and ability to pass through the
upper gastrointestinal tract unaffected by bile acids and
proteolytic enzymes are prerequisites for microorgan-
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probiotics belong to the genera Lactobacillus and
Bifidobacterium, but other genera, including Escher-
ichia, Enterococcus, Bacillus and Saccharomyces,a r e
also commonly used, based on documented efficacy
through clinical studies (Gibson et al. 2004). Their
main beneficial effects are those provided by a non-
compromised, healthy gut microbiota: the competition
with pathogens for the adhesion to the gut epithelium,
the production of substances that inhibit the growth of
potentially harmful bacteria (i.e. organic acids, bacter-
iocins, hydrogen peroxide), the synthesis of water
soluble vitamins and the modulation of the immune
processes (Chermesh and Eliakim 2006;M a c f a r l a n ee t
al. 2007; Park and Floch 2007;N e i s h2009).
Prebiotics are chemical substances, usually oligo-
saccharides, acting as substrates specifically for the
host’s autochthonous probiotic bacteria and thus
promoting their growth (Gibson and Roberfoid
1995). Prebiotics are selected as being non-digestible
by the host and non-metabolizable by non-probiotic
gut bacteria (Gibson et al. 2004). The most common
prebiotics are inulin, its fructo-oligosaccharides (FOS)
derivatives and galacto-oligosaccharides (GOS), but
other complex saccharides and fibres have been
recently presented as candidate prebiotics (Candela
et al. 2010). Because of their safety and stability, FOS
and GOS are being increasingly used in Western diet,
being incorporated into a wide range of commercial
products, from bakery to dairy, as well as in infant-
and animal-specific foods (Macfarlane et al. 2007).
One of the most important beneficial activities of
prebiotics, aside from the bifidogenic effect, is to act
as substrate for fermentative processes whose end
products are SCFAs. On the whole, pro/prebiotics
have the potential of being helpful in the prevention
and therapy of metabolic- and malnutrition-related
conditions, as well as in a variety of pathological
conditions, including inflammatory diseases and
colon cancer (Candela et al. 2011).
Critical points in the modulation of the gut
microbiota in elderly healthcare
Improvingthe level ofhealthamongolder peoplecan—
andmust—beoneoftheaimsofmoderngerontology,in
order to decrease the rate of hospitalisation, the
administration of drugs and, consequently, the health-
care cost of the ageing population. A healthier nutrition
is one of the first strategies that can be employed to
preserve health during ageing. The development of
‘elderlyspecific’functionalfoods,containingprobiotics
and/or prebiotics, may help in preventing the disruption
of the gut environment. Moreover, since older people
are the most prominent users of antibiotics because of
their increased susceptibility to infections, the adminis-
tration of probiotics and prebiotics during/after drug
treatments may be particularly important, in order to
preserve/restore homeostasis between microbiota and
the gut IS and prevent the occurrence of antibiotic-
associated GI disturbances.
Evidence of the decline of bifidobacteria and other
health-promoting bacteria in the gut of ageing subjects
opens up the possibility of reversing such a trend by
administration of probiotics, prebiotics or synbiotics
(a mixture of prebiotics and one or more probiotic
strains). It has been demonstrated that supplementation
of probiotic Bifidobacterium strains significantly
increases the levels of health-promoting bacteria in
the faecal microbiota of elderly (Amhed et al. 2007;
Lahtinen et al. 2009; Matsumoto et al. 2009). FOS and
GOS ingestion, as well as symbiotic preparations, were
reported to significantly increase the numbers of
bifidobacteria at the expense of less beneficial groups
in elderly individuals (Guigoz et al. 2002;B a r t o s c he t
al. 2005; Bouhnik et al. 2007; Vulevic et al. 2008).
However, the administration of functional preparations
needs to be underpinned by evidence of a true
therapeutic effect (e.g. alleviate constipation or diar-
rhoea) reported by the enrolled patients, not just to
increase or decrease specific bacterial groups, in order
for the change to be considered beneficial. Generating
such evidence is a challenge, and it is even more
difficult to ascertain the ability of pro/prebiotics to
prevent age-related disturbances.
Nevertheless, probiotics, prebiotics and synbiotics
are commonly believed to be useful (or hold potential
promise) in promoting certain aspects of health in
elderly people (Tiihonen et al. 2010). In the sections
below, the most relevant results regarding the use of
functional preparations in several common age-related
conditions will be discussed.
Pro/prebiotics and constipation
Pro/prebiotics are believed to have therapeutic poten-
tial for the treatment of constipation, principally
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biota structure. The gut microbiota of chronically
constipated people is believed to be different from the
healthy situation, but whether the dysbiosis is either a
secondary effect of constipation or a contributing
cause is still an open question.
Clinical trials reporting evidence of the efficacy of
probiotic administration in improving constipation in
ageing people are very few and, again, barely
comparable. All of them (Pitkala et al. 2007; Carlsson
et al. 2009; An et al. 2010) involve elderly people
living in nursing homes. Selection of these volunteers
is justified by the higher incidence of constipation
among ‘institutionalised’ elderly (Gallagher and
O’Mahony 2009; Spinzi et al. 2009; An et al. 2010)
and has the advantage of providing a highly homo-
geneous population with regard to nutritional habits
and lifestyle, but this low variability does not reflect
the situation of the free-living elderly population.
Consequently, the findings from those trials should
not be considered generally applicable. Moreover,
only the study of Pitkala et al. (2007) was performed
on a large number of subjects (n=209) and reported
the ability of two strains of Bifidobacterium longum
and Bifidobacterium lactis to increase the frequency
of bowel movements in institutionalised Finnish
elderly. By comparison, the clinical trials undertaken
by Carlsson et al. (2009) and An et al. (2010)
involved 15 and 19 nursing home residents, respec-
tively. The first was presented as a pilot study to
evaluate the feasibility of a probiotic treatment on
institutionalised aged people with dementia in Swe-
den, but the results obtained were not promising:
Strains of Lactobacillus rhamnosus and Lactococcus
lactis were not able to produce detectable effects on
constipation. Conversely, An et al. showed that a
probiotic mixture of Lactobacillus acidophilus, Ped-
iococcus pentosaceus and B. longum was able to
significantly improve frequency of defecation, state
a n da m o u n to fs t o o l ,i nK o r e a nn u r s i n gh o m e
residents.
It is quite clear that these studies are too few and
involve too few subjects; even if the results of Pitkala
et al. (2007) and An et al. (2010) were statistically
significant, the conclusions should be interpreted with
great caution. As for the prebiotics, only one study
has been published evaluating the effect of inulin and
lactose specifically on the bowel habits of elderly
constipated people (Kleessen et al. 1997). The results
of this clinical trial were promising: The ingestion of
inulin improved constipation in nine out of ten
subjects, with only mild discomfort (flatulence). More
recently, Ouwehand et al. (2009) reported a slight
increase in stool frequency in healthy elderly taking a
synbiotic preparation (lactitol and L. acidophilus
NCFM), but the efficacy of this synbiotic preparation
was not tested on constipated people.
The effect of pro/prebiotics on functional consti-
pation is still to be demonstrated for both paediatric
and adult population (Chmielewska and Szajewska
2010). In the case of the elderly population, the need
for studies involving high number of chronically
constipated subjects is even more evident.
Pro/prebiotics and C. difficile-associated diarrhoea
The disruption of the gut microbiota balance, which
occurs through the use of broad-spectrum antibiotics, is
believed to be responsible for the increased susceptibil-
ity to CDAD (Hopkins and Macfarlane 2002; Pultz and
Donskey 2005; Chang et al. 2008). Given the inhibi-
tory effect of a healthy gut microbiota on C. difficile
overgrowth and toxin release, the active reconstitution
of a ‘normal’ microbiota is theoretically attractive, and
the use of probiotics to prevent/treat CDAD is gaining
a considerable interest (Leffler and Lamont 2009;
Parkes et al. 2009). Many health-promoting strains,
belonging to the genera Lactobacillus, Bifidobacterium
and Saccharomyces, have been tested on human adults.
Even if the results seem promising for what concerns
the prophylactic use of probiotics (McFarland 2006),
the evidence suggested that probiotics may be able to
provide modest or no benefit in the therapy of CDAD
(Pillai and Nelson 2008). As for the elderly, the
possibility to use pro/prebiotics in the prevention of
CDAD is still in its infancy: Only Hickson et al. (2007)
reported a reduction in CDAD incidence and an
absence of C. difficile toxin in the faeces of elderly
treated with Lactobacillus casei.
Another possibility in the treatment of CDAD is
the reconstitution of a healthy gut microbiota through
stool transplantation from a healthy donor. In spite of
the hypothetical danger to spread pathogenic bacteria
from the donor to the patient, there is growing interest
in this approach resulting from its documented
efficacy on both recurrent (Persky and Brandt 2000)
and acute (You et al. 2008) CDAD. The use of this
technique on older patients is not very well reported
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may call for future research focused on this specific
population which represents a growing sector of the
healthcare cost in Western countries.
Pro/prebiotics and the functionality of the immune
system
Immunostimulatory properties, such as modulation of
cytokines production or adjuvant effects on T lym-
phocytes and natural killer (NK) cells activity, have
been demonstrated for various health-promoting
Lactobacillus and Bifidobacterium strains (Meydani
and Ha 2000; Blum et al. 2002). A complete analysis
of the in vivo studies demonstrating immunomodula-
tory effects of pro/prebiotics on human subjects is far
beyond the aim of this review and has been addressed
elsewhere (Nova et al. 2007; Lomax and Calder
2009), but it seems that pro/prebiotics have the
potentiality to enhance the immune response and
modify some inflammatory conditions (Saulnier et al.
2009; Antoine 2010). In the elderly, probiotics and
prebiotics have been suggested as having the potential
to restore immune functions (Candore et al. 2008)
and, consequently, to help in preventing and/or
limiting the effects of immunosenescence.
Earlier studies showed that 3- and 6-week interven-
tions with B. lactis can have positive effects on the IS of
old people, such as increases of NK cells tumouricidal
activity and monocytes phagocytic capacity (Chiang et
al. 2000; Arunachalam et al. 2000; Gills et al. 2001a, b).
Similar results were also described following supple-
mentation of L. rhamnosus (Sheih et al. 2001)a n dL.
casei Shirota (Takeda and Okumura 2007).
A study focused on a particular population of
hospitalised, enterally fed elderly demonstrated that
the level of the pro-inflammatory cytokine TNF-α
decreased in response to supplementation of fer-
mented milk containing a probiotic strain of Lacto-
bacillus; the elderly volunteers also showed a decline
in the incidence of infections (Fukoshima et al. 2007).
A probiotic yogurt supplementation was also tested
on elderly affected by intestinal bacterial overgrowth
and was able to normalise the response to endotoxin
and modulate inflammatory markers in blood phag-
ocytes (Schiffrin et al. 2009b).
Supplementation of Lactobacillus and Bifidobacte-
rium strains was also positively correlated with the
spermine and spermidine levels, which has been
suggested to be associated with reduced inflammation
(Matsumoto and Benno 2006). Most recently, Ibrahim
et al. (2010) demonstrated that a commercial probiotic
cheese containing L. rhamnosus and L. acidophilus
was able to improve NK cells ability to kill target
tumour cells and the phagocytosis activity of gran-
ulocytes and monocytes.
Significant increase of phagocytosis, NK cell
activity and production of the regulatory cytocine
IL-10 were also reported following FOS and GOS
supplementation in elderly volunteers, together with a
reduction in the production of pro-inflammatory
cytokines (IL-6, IL-1β and TNF-α; Guigoz et al.
2002; Schiffrin et al. 2007; Vulevic et al. 2008).
As for the effects of synbiotic preparations, results
are still preliminary. Ouwehand et al. (2009) reported
an improved mucosal integrity, evaluated as increased
faecal levels of spermidine and other intestinal
immune markers, following the administration of L.
acidophilus and lactitol.
Most of the results summarized above were
obtained in studies involving subjects with a great
variability in nationality and range of age. Confirma-
tion of the results, as well as more insights in the
cross talk between gut microbiota and IS, are needed,
especially in the perspective of the development of
nutritional strategies targeting the mucosal-host reac-
tivity. Moreover, even if some of the results seem
promising, parameters need to be established to
evaluate the practical significance of the effects of
pro/prebiotic treatments on the IS.
An interesting decrease in the duration, but not in
the incidence, of respiratory and gastrointestinal
‘winter infections’ in 360 free-living elderly was
reported following a 3-week L. casei supplementation
(Turchet et al. 2003). This trend was recently
confirmed in a larger (1,072 elderly volunteers),
multicentric, double-blind, controlled trial using the
same probiotic species (Guillermard et al. 2010).
Since ‘common’ infectious diseases, such as respira-
tory tract infections, flu and flu-like syndromes, acute
otitis and sinusitis and gastroenteritis, are more
frequent and severe in the ageing population, remain-
ing a considerable cause for morbidity and mortality
(Gavazzi and Krause 2002), these results may be of
interest: Reducing the duration of infections of 1 or
2 days may not appear important in terms of
individual health, but if the cost of 1 day of hospital-
isation is considered the community benefit becomes
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showed that in two clinical trials, performed on 86 and
222 elderly subjects, the consumption of a probiotic
drink containing L. casei for several weeks before and
after flu vaccination was correlated to a significant
increase in the influenza-specific antibody titre. This
seems to demonstrate the potential of probiotics to be
helpful also in improving the clinical protective efficacy
of flu vaccine in the elderly population, in which it is
usually considerably reduced (Goodwin et al. 2006).
Concluding remarks
Ageing presents a major nutritional challenge, not only
in relation to the dietary supply of certain nutrients but
also their metabolism. Physiological and other age-
related changes may lead to inadequate nutrition unless
diets are modified to improve the nutrientdensity and to
incorporate food constituents that maintain optimal
nutrient status and promote health. Micronutrient
deficiencies, which are not uncommon in the elderly,
areassociatedwithadeclineinbodyfunctionwhichcan
lead to a higher risk of infections and chronic disease.
Low-gradeinflammationishypothesisedtobecentralto
the pathogenesis of several chronic diseases (van
Ommen et al. 2008), and although multiple micronu-
trient supplements have been reported to reduce the
inflammatory status associated with obesity (Bakker et
al. 2010), the effect on age-related inflammation
requires investigation. Many studies demonstrated that
the dynamics involved in the ageing process of the
human metaorganism implies a strong modulation in
its microbial counterpart. Establishing a vicious circle,
the aged-type microbiota contributes to the pathophys-
iological process of ageing affecting nutrition, inflam-
matory status and susceptibility to infection. However,
our knowledge of the gut microbiota composition of
elderly people is still far from complete.
We propose a general and preliminary model of the
dynamics of the intestinal microbiota with ageing
(Fig. 2). According to this model, the ageing process
of the human intestinal microbiota implies a substantial
reduction of its microbial biodiversity, driving towards
an aged-type microbial ecosystem that resembles the
infant-type microbiota. In fact, both the infant-type and
the aged-type are characterised by lower biodiversity,
higher abundance of opportunistic environmental
aerobes and fewer symbiont anaerobes. However, even
if they are comparable in terms of biodiversity, the
aged- and infant-type microbiota live in completely
different gastrointestinal habitat, and the functional
outcome of the microbiota–host interaction is abso-
lutely different. Whereas the threshold for the transi-
tion from infant-type to adult-type is defined by
weaning, the ageing process shows a striking subject
specificity. In fact, ageing-associated modifications of
the gut microbiota depend on individual-specific char-
acteristics such as diet and nationality, which can
dramatically impact on the microecology of the human
GI tract. For these reasons, future research will have to
be carefully structured, especially during the recruit-
ment procedure, providing detailed information on the
nationality, age range and the health parameters of the
participants, and molecular characterisation approaches
will have to be used on a large number of subjects.
Even less is known about the involvement of the gut
microbial ecosystem in the inflamm-aging process and
in the decline in the functionality of the IS. It is possible
that the ageing-associated inflammatory status may be
amongst the causes of the changes occurring in the gut
microbiota composition. At the same time, the compro-
mised balance of the gut microbiota may nurture the
inflammation, creating a self-sustaining cycle.
The administration of health-promoting bacteria
and/or prebiotic fibres to elderly patients is reported to
induce changes in several immune and inflammatory
parameters, demonstrating that the manipulation of
the gut microbiota may result in modification of the
functionality of an aged IS. Even if the possibility of
keeping immunosenescence and inflamm-aging under
control by a simple supplementation and/or functional
food is fascinating, the concept of ‘immunonutrition’
is still in its infancy and needs to be better related to
the health, immunological and nutritional status of the
considered elderly people, as well as their nationality
and actual age. Moreover, the eventual ‘improve-
ment’ in the immune and inflammatory status of
elderly involved in feeding trials needs to be better
defined, in terms of a true health advantage: Until
now, only a shorter duration of common infectious
diseases has been reported as a positive effect of a
probiotic supplementation, but not a decrease in
the infection incidence. Our critical analysis of the
application of pro/prebiotics in distinctive intestinal
conditions of elderly people (i.e. constipation and
CDAD) also highlighted the fact that very limited
clinical evidence is available for the efficacy of
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treatment of these disorders.
In conclusion, even if pro/prebiotics have the potential
to become a useful support in the development of
‘personalized’ nutritional strategies to improve/preserve
the health status of the ageing population, more carefully
designed and controlled studies, with higher numbers of
subjects, are needed to determine whether and under
what conditions they can be truly helpful.
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Fig. 2 Every time a human baby is born, a rich and dynamic
microbial ecosystem develops from a sterile environment.
During the first year of life, until weaning, the gut ecosystem
is prevalently colonized by opportunistic microorganisms to
which a baby is exposed in its environment (Palmer et al.
2007). The earliest colonizers are often aerobes such as
Staphylococcus, Streptococcus and Enterobacteria, followed
by anaerobic later colonizers such as Eubacteria and Clostridia.
After these earlier stages, it is generally though that the
microbiota of breast-fed infants is largely dominated by
Bifidobacterium. After weaning, the developmental changes in
the gut mucosa and in the intestinal IS, together the
introduction of a solid diet, drive to the transition to a resilience
adult-like profile of the human gut microbiota, characterised by
a remarkable microbial biodiversity. The ageing of the gut
microbiota starts after a subject-specific ‘threshold age’ which
depends on individual characteristics such as diet, country and,
eventually, frailty. In any case, changes of diet, lifestyle and the
immunosenescence of the intestinal IS dramatically impact the
microbial ecology of the human GI tract. Symmetrically to
what happens in the early stage of our life, the aged-type
microbiota shows a low microbial biodiversity, and it is
characterised by an increase in opportunistic environmental
facultative aerobes Staphylococcus, Streptococcus, Enterobac-
teriaceae, as well as a reduction in anaerobes, such as
Clostridium clusters IV and XIVa and Bacteroidetes. However,
differently from the infant-type microbiota, the aged type is
characterised by a low abundance of Bifidobacterium
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